VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $6,386,000 | -61.5% | 62,825 | -32.4% | 0.92% | -58.4% |
| Q3 2015 | $16,575,000 | -21.7% | 92,920 | -2.5% | 2.22% | -9.9% |
| Q2 2015 | $21,169,000 | +32467.7% | 95,290 | +29220.0% | 2.47% | +35185.7% |
| Q1 2015 | $65,000 | -99.6% | 325 | -99.7% | 0.01% | -99.7% |
| Q4 2014 | $17,569,000 | +53139.4% | 122,768 | +49403.2% | 2.06% | +51450.0% |
| Q3 2014 | $33,000 | -99.3% | 248 | -99.4% | 0.00% | -99.5% |
| Q2 2014 | $5,034,000 | +27.6% | 39,918 | +33.4% | 0.82% | -8.1% |
| Q1 2014 | $3,944,000 | +20.4% | 29,918 | +7.3% | 0.89% | -15.4% |
| Q4 2013 | $3,275,000 | +146.4% | 27,895 | +119.0% | 1.06% | +45.1% |
| Q3 2013 | $1,329,000 | – | 12,736 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |